Article
The m1A-SFRP2-NFAT/TOX axis governs T cell exhaustion in gastric cancer
11 Aug 2025
Abstract excerpt
While immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, their efficacy in gastric cancer (GC) remains limited, underscoring the need for mechanistic biomarkers of immune evasion. We analyzed m 1 A RNA modification patterns in the TCGA-STAD cohort, stratifying patients into three subtypes. Functional assays (including CRISPR-based SFRP2 modulation, NFAT/TOX reporter systems, and ex vivo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
